MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fmed.2025.1579285

Медицинская библиотека · Frontiers in medicine · 2025

GPR83 protects cochlear hair cells against ibrutinib-induced hearing loss through AKT signaling pathways.

Zhang Yuhua, Xiao Yun, Zhu Yongjun, Yan Lin, Cheng Nan, Wei Yongjie, Zhang Yanling, Tian Yanghua, Cao Wei, Yang Jianming

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Ibrutinib, widely used in leukemia treatment, has been implicated in sensorineural hearing loss; however, its underlying mechanisms remain unclear.

METHODS

This study investigated the impact of ibrutinib on hearing using HEI-OC1 cells, cochlear explants and C57BL/6 J mice. We used RNA-sequences analysis to investigate the potential mechanisms of ibrutinib-induced ototoxicity. Mice received ibrutinib and auditory thresholds were assessed via auditory brainstem response testing; to assess the potential protective effects, we co-administered the caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethylketone (Z-VAD-FMK) and monitored hearing.

RESULTS

Z-VAD-FMK mitigated ibrutinib-induced hearing loss by inhibiting apoptosis in auditory cells. Ibrutinib exposure resulted in cochlear hair cell (HC) damage and subsequent hearing loss by inhibiting the protein kinase B and G protein-coupled receptor 83 (GPR83) pathways. RNA sequencing suggested that GPR83 protects HCs by modulating autophagy. Z-VAD-FMK application and GPR83 overexpression attenuated ibrutinib-induced cochlear HC apoptosis and auditory decline.

CONCLUSION

These findings confirm ibrutinib's ototoxicity and highlight the protective role of GPR83 in ibrutinib-induced hearing loss, supporting future clinical investigations into Z-VAD-FMK and GPR83 as interventions for ibrutinib or other chemotherapeutic drug-induced ototoxicity.

Для цитирования: Zhang Yuhua, Xiao Yun, Zhu Yongjun, Yan Lin, Cheng Nan, Wei Yongjie, Zhang Yanling, Tian Yanghua, Cao Wei, Yang Jianming. GPR83 protects cochlear hair cells against ibrutinib-induced hearing loss through AKT signaling pathways.. Frontiers in medicine. 2025. DOI: 10.3389/fmed.2025.1579285.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.